Spero Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

Phase 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Number of Participants With Overall Response at the Test-of-Cure (TOC) Visit. After: Measure: Number of Participants With Overall Response at the Test-of-Cure (TOC) Visit in the Microbiological Intent-to-Treat (Micro-ITT) Population.

Actual enrollment increased by 958 participants

Before: 1690 participants (actual). After: 2648 participants (actual).

Check registry source